These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1135 related items for PubMed ID: 27729780

  • 1. Prevalence of undiagnosed airflow obstruction among people with a history of smoking in a primary care setting.
    Fu SN, Yu WC, Wong CK, Lam MC.
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2391-2399. PubMed ID: 27729780
    [Abstract] [Full Text] [Related]

  • 2. Comparison of the COPD Population Screener and International Primary Care Airway Group questionnaires in a general Japanese population: the Hisayama study.
    Tsukuya G, Samukawa T, Matsumoto K, Fukuyama S, Kumamoto T, Uchida A, Koriyama C, Ninomiya T, Inoue H.
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1903-9. PubMed ID: 27574414
    [Abstract] [Full Text] [Related]

  • 3. The relationship between the COPD Assessment Test score and airflow limitation in Japan in patients aged over 40 years with a smoking history.
    Yoshimoto D, Nakano Y, Onishi K, Hagan G, Jones P.
    Int J Chron Obstruct Pulmon Dis; 2014; 9():1357-63. PubMed ID: 25525353
    [Abstract] [Full Text] [Related]

  • 4. Respiratory and Bronchitic Symptoms Predict Intention to Quit Smoking among Current Smokers with, and at Risk for, Chronic Obstructive Pulmonary Disease.
    Melzer AC, Feemster LC, Crothers K, Carson SS, Gillespie SE, Henderson AG, Krishnan JA, Lindenauer PK, McBurnie MA, Mularski RA, Naureckas ET, Pickard AS, Au DH, COPD Outcomes-based Network for Clinical Effectiveness and Research Translation Consortium.
    Ann Am Thorac Soc; 2016 Sep; 13(9):1490-6. PubMed ID: 27268422
    [Abstract] [Full Text] [Related]

  • 5. Prevalence of COPD among symptomatic patients in a primary care setting.
    Yawn B, Mannino D, Littlejohn T, Ruoff G, Emmett A, Raphiou I, Crater G.
    Curr Med Res Opin; 2009 Nov; 25(11):2671-7. PubMed ID: 19757984
    [Abstract] [Full Text] [Related]

  • 6. Prevalence and diagnosis of chronic obstructive pulmonary disease among smokers at risk. A comparative study of case-finding vs. screening strategies.
    Sansores RH, Ramírez-Venegas A, Hernández-Zenteno R, Mayar-Maya ME, Pérez-Bautista OG, Velázquez Uncal M.
    Respir Med; 2013 Apr; 107(4):580-6. PubMed ID: 23313037
    [Abstract] [Full Text] [Related]

  • 7. Smoking duration, respiratory symptoms, and COPD in adults aged ≥45 years with a smoking history.
    Liu Y, Pleasants RA, Croft JB, Wheaton AG, Heidari K, Malarcher AM, Ohar JA, Kraft M, Mannino DM, Strange C.
    Int J Chron Obstruct Pulmon Dis; 2015 Apr; 10():1409-16. PubMed ID: 26229460
    [Abstract] [Full Text] [Related]

  • 8. Voluntary lung function screening to reveal new COPD cases in southern Italy.
    Capozzolo A, Castellana G, Dragonieri S, Carratù P, Liotino V, Vulpi MR, Marra L, Resta E, Intiglietta P, Resta O.
    Int J Chron Obstruct Pulmon Dis; 2017 Apr; 12():2035-2042. PubMed ID: 28744118
    [Abstract] [Full Text] [Related]

  • 9. The Prevalence of Chronic Obstructive Pulmonary Disease by the Global Lung Initiative Equations in North-Western Russia.
    Andreeva E, Pokhaznikova M, Lebedev A, Moiseeva I, Kutznetsova O, Degryse JM.
    Respiration; 2016 Apr; 91(1):43-55. PubMed ID: 26727503
    [Abstract] [Full Text] [Related]

  • 10. Development of a simple binary response questionnaire to identify airflow obstruction in a smoking population in Argentina.
    Bergna MA, García GR, Alchapar R, Altieri H, Casas JC, Larrateguy L, Nannini LJ, Pascansky D, Grabre P, Zabert G, Miravitlles M.
    Eur Respir Rev; 2015 Jun; 24(136):320-6. PubMed ID: 26028643
    [Abstract] [Full Text] [Related]

  • 11. Different impacts of respiratory symptoms and comorbidities on COPD-specific health-related quality of life by COPD severity.
    Lee H, Jhun BW, Cho J, Yoo KH, Lee JH, Kim DK, Lee JD, Jung KS, Lee JY, Park HY.
    Int J Chron Obstruct Pulmon Dis; 2017 Jun; 12():3301-3310. PubMed ID: 29180860
    [Abstract] [Full Text] [Related]

  • 12. Misidentification of airflow obstruction: prevalence and clinical significance in an epidemiological study.
    Pothirat C, Chaiwong W, Phetsuk N, Liwsrisakun C.
    Int J Chron Obstruct Pulmon Dis; 2015 Jun; 10():535-40. PubMed ID: 25792821
    [Abstract] [Full Text] [Related]

  • 13. Implementation of a targeted screening program to detect airflow obstruction suggestive of chronic obstructive pulmonary disease within a presurgical screening clinic.
    Robitaille C, Dajczman E, Hirsch AM, Small D, Ernst P, Porubska D, Palayew M.
    Can Respir J; 2015 Jun; 22(4):209-14. PubMed ID: 25961279
    [Abstract] [Full Text] [Related]

  • 14. A comprehensive analysis of association of medical history with airflow limitation: a cross-sectional study.
    Nishida Y, Takahashi Y, Tezuka K, Yamazaki K, Yada Y, Nakayama T, Asai S.
    Int J Chron Obstruct Pulmon Dis; 2017 Jun; 12():2363-2371. PubMed ID: 28848337
    [Abstract] [Full Text] [Related]

  • 15. Prevalence of airway obstruction assessed by lung function questionnaire.
    Mintz ML, Yawn BP, Mannino DM, Donohue JF, Hanania NA, Grellet CA, Gilsenan AW, McLeod LD, Dalal AA, Raphiou IH, Prillaman BA, Crater GD, Cicale MJ, Mapel DW.
    Mayo Clin Proc; 2011 May; 86(5):375-81. PubMed ID: 21531880
    [Abstract] [Full Text] [Related]

  • 16. Comorbidity in chronic obstructive pulmonary disease. Related to disease severity?
    Echave-Sustaeta JM, Comeche Casanova L, Cosio BG, Soler-Cataluña JJ, Garcia-Lujan R, Ribera X.
    Int J Chron Obstruct Pulmon Dis; 2014 May; 9():1307-14. PubMed ID: 25429213
    [Abstract] [Full Text] [Related]

  • 17. Factors associated with inadequate diagnosis of COPD: On-Sint cohort analysis.
    Fernández-Villar A, López-Campos JL, Represas Represas C, Marín Barrera L, Leiro Fernández V, López Ramírez C, Casamor R.
    Int J Chron Obstruct Pulmon Dis; 2015 May; 10():961-7. PubMed ID: 26028969
    [Abstract] [Full Text] [Related]

  • 18. Prevalence, Symptom Burden, and Underdiagnosis of Chronic Obstructive Pulmonary Disease in a Lung Cancer Screening Cohort.
    Ruparel M, Quaife SL, Dickson JL, Horst C, Tisi S, Hall H, Taylor MN, Ahmed A, Shaw PJ, Burke S, Soo MJ, Nair A, Devaraj A, Sennett K, Hurst JR, Duffy SW, Navani N, Bhowmik A, Baldwin DR, Janes SM.
    Ann Am Thorac Soc; 2020 Jul; 17(7):869-878. PubMed ID: 32164439
    [Abstract] [Full Text] [Related]

  • 19. Prevalence of airflow obstruction according GOLD, ATS and ERS criteria in symptomatic ever-smokers referring to a pulmonary rehabilitation department.
    Barbarito N, Vaghi A, De Mattia E.
    Monaldi Arch Chest Dis; 2011 Sep; 75(3):157-61. PubMed ID: 22428217
    [Abstract] [Full Text] [Related]

  • 20. FEV6 assessment in spirometric abnormalities screening: the first population-based study in Italian pharmacies.
    Solidoro P, Braido F, Baratta F, Bagnasco D, Esposito R, Aggeri M, Brusa P.
    Panminerva Med; 2013 Mar; 55(1):87-92. PubMed ID: 23474666
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 57.